BIOLIFE SOLUTIONS INC holding history
As of Nov. 6, 2026 (UTC)
| March 31, 2025 | 497,231 | $11,356,756 | 0.16% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | May 1, 2025 |
| June 30, 2025 | 531,719 | $11,453,227 | 0.15% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | July 30, 2025 |
| Sept. 30, 2025 | 608,814 | $15,530,845 | 0.20% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Oct. 28, 2025 |
| Dec. 31, 2025 | 606,887 | $14,674,528 | 0.19% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | Feb. 5, 2026 |
| March 31, 2026 | 673,129 | $12,843,301 | 0.18% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | April 28, 2026 |
| June 30, 2026 | 708,666 | $20,012,728 | 0.21% | Withheld — Comparison unavailable: Comparable change withheld pending corporate-action review | July 29, 2026 |
6 rows · Sort by column; scroll horizontally for more.
No rows match these filters.
Schedule 13G disclosures
No verified related disclosures are included in this freeze.
About reported holdings
13F reports quarter-end securities, excluding cash and shorts. Position changes do not establish trades, motives or returns; portfolio weights use disclosed 13F value.